201 related articles for article (PubMed ID: 23017088)
21. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
[TBL] [Abstract][Full Text] [Related]
22. [Recent progress in developing of thrombolytic agents for ischemic stroke].
Xu Y; Chen S; Chen D; Peng S; Cheng Y; Li J; Li Y; Jiang L; Yuan C; Huang M
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2029-2039. PubMed ID: 33169568
[TBL] [Abstract][Full Text] [Related]
23. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
24. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
25. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
[TBL] [Abstract][Full Text] [Related]
26. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
Liu S; Feng X; Jin R; Li G
Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
[TBL] [Abstract][Full Text] [Related]
27. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
[TBL] [Abstract][Full Text] [Related]
28. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
[TBL] [Abstract][Full Text] [Related]
29. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
[TBL] [Abstract][Full Text] [Related]
30. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.
Parsons MW; Barber PA; Chalk J; Darby DG; Rose S; Desmond PM; Gerraty RP; Tress BM; Wright PM; Donnan GA; Davis SM
Ann Neurol; 2002 Jan; 51(1):28-37. PubMed ID: 11782981
[TBL] [Abstract][Full Text] [Related]
31. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
Kwon JH; Shin SH; Weon YC; Hwang JC; Baik SK
Neuroradiology; 2011 Oct; 53(10):779-85. PubMed ID: 21808986
[TBL] [Abstract][Full Text] [Related]
32. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
[TBL] [Abstract][Full Text] [Related]
33. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
[TBL] [Abstract][Full Text] [Related]
35. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
36. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
[TBL] [Abstract][Full Text] [Related]
37. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
38. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
[TBL] [Abstract][Full Text] [Related]
39. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
40. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
Cronin CA; Langenberg P; Dutta TM; Kittner SJ
Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
